Skip to content
Accelerator Atlas

What Follow-On Checks By Subsector Actually Tell You About a 'Vertical' Accelerator

Accelerators market themselves as fintech or biotech specialists, but rarely show which subsectors they actually follow on in after the check clears. This piece gives founders the specific questions to ask before applying, not after signing a SAFE.

Oct 15, 2026
What Follow-On Checks By Subsector Actually Tell You About a 'Vertical' Accelerator

The question founders should be asking: what does this accelerator actually follow on in?

A fintech accelerator says it specializes in fintech. A biotech accelerator says it specializes in biotech. Neither of those sentences tells you what you actually need to know, which is: once a cohort ends, where does this program put its follow-on money?

That's a different question than "what verticals does this program accept applications from." A program can be stacked with payments alumni, three of whom raised strong follow-on rounds the program itself participated in, and have written zero follow-on checks into lending startups, ever. It still calls itself a fintech accelerator. Nothing about that label is false. It's just incomplete in a way that matters a lot if your startup is a lending company.

Same pattern in biotech. A program can be genuinely excellent at therapeutics, with real conviction and a track record to show for it, and have almost no history backing diagnostics companies past the check that got them into the cohort. "Biotech-focused" covers both. The marketing doesn't split the difference, and most founders never ask it to.

Why this gap is so hard to see from outside

Here's the structural problem: almost no accelerator publishes follow-on data broken out by subsector. You'll see aggregate numbers on a website, like total alumni funded or total capital raised across the portfolio, because those numbers look good in a one-pager. You will rarely see "of our twelve lending-focused companies, we followed on in one." That number is harder to find because most programs haven't organized their own data that way, or because publishing it would surface an uneven track record.

Either way, the result for the founder applying is the same: vertical expertise gets taken on faith. You read the website, you see familiar logos on a partnerships slide, you assume the conviction is evenly spread across whatever subsectors the program lists. Then you apply, you get in, you sign a SAFE, you give up equity, and you find out three cohorts in that this program has never once followed on in your specific subsector. By then the equity is gone and the deadline that would have let you apply elsewhere has usually passed too.

We've written before about whether a biotech accelerator actually funds your subsector and about checking a vertical accelerator's actual track record. This piece is about the specific question that sits underneath both: not just "has this program placed companies in my subsector," but "has this program put its own money behind them after the first check."

A fintech example, made concrete

Imagine a fintech accelerator with alumni across payments, lending, and insurtech. Say it followed on in four payments companies over the last two cohorts. Say it followed on in zero lending companies in that same window, despite accepting lending startups into every cohort. That program is not lying when it calls itself a fintech accelerator. But a lending founder applying there is making a very different bet than a payments founder is, and the website gives them no way to tell the difference.

What to ask before you apply, not after

Ask the program directly, before you submit an application, not during diligence after you've already been accepted:

  • Which subsectors has this program written follow-on checks into, specifically, and how many?
  • How recently? A follow-on check from several cohorts ago tells you less than one from the most recent cycle.
  • Is any of this documented anywhere besides a pitch deck or a demo-day recap? A partner press release, a portfolio page with round details, anything with a date on it.
  • If the program can't answer, ask why. "We don't track it that way" is a real answer. It's also useful information: it tells you the program's own data discipline is thin, which should make you more skeptical of every other claim on its site, not less.

If you want the plain-English version of the glossary terms that come up once you get this far (SAFE, MFN, pro-rata, check size), that's worth reading before you're mid-negotiation, not during it.

How Accelerator Atlas handles the parts it can verify

We can't always get a program's internal follow-on data broken out by subsector. Almost nobody publishes it cleanly. What we do instead is apply the same standard to this as we do to everything else in the directory: show the source, show the check-date, and show a blank rather than a guess.

Every one of the 105 US accelerator programs in Accelerator Atlas carries a confidence tier: Verified, Secondary, or Unverified. Of those 105, 102 are verified against the program's own primary documents, not scraped summaries or secondhand writeups. When a claim about vertical focus or follow-on conviction can't be confirmed against a primary source, we don't round it up to sound more impressive. We leave it unverified, because a blank you can trust is worth more than a number you can't.

That same discipline is what we apply to the terms founders actually sign: check size, equity percentage, deadlines. If you're trying to sort out whether a program's demonstrated conviction matches its marketing, you can compare programs side by side using the same source-and-check-date standard, rather than taking a "vertical focus" claim at face value.

Ask the subsector question before the deadline, not after the cohort starts

Right now, with fintech, biotech, and climate application windows closing across the fall wave, founders are choosing where to spend equity they don't get back. That's exactly the moment to ask the follow-on question, not three months into a cohort when the answer is a lot more expensive to learn.

Before you apply to a fintech, biotech, or climate accelerator this season, pull up its actual terms (check size, equity, source, check-date) in the Accelerator Atlas directory and compare them side by side. If a program can't show its work on subsector follow-on conviction, treat it as Unverified until it can. Your equity is the one thing you can't ask for back after the demo day lights go down.

Frequently asked

How do I ask an accelerator about its follow-on investment history by subsector?

Ask directly: which companies in which subsectors got follow-on checks, and when. Ask if that's documented anywhere beyond a pitch deck, like a portfolio page or press release. A program with real conviction in a subsector can usually name the company and the round. If the answer is vague or deflects to 'we support all our founders,' that's your answer too.

Is a biotech accelerator equally good at every subsector it lists?

Almost never. A program can be deep in therapeutics, with multiple follow-on checks and alumni who raised Series A, while being shallow in diagnostics, with zero follow-on history there. The label 'biotech accelerator' covers both. You have to ask which subsector the program has actually backed after the check cleared, not just which subsectors it accepts applications from.

Why don't accelerators publish follow-on data broken out by subsector?

Most programs aren't required to, and aggregate portfolio stats (total alumni, total follow-on raised) make for a cleaner one-pager than a subsector breakdown that might show weak spots. That's not necessarily dishonest, but it does mean the burden is on the founder to ask before applying, not after signing a SAFE.

New posts in your inbox

One digest a week. Deadline alerts only for verticals you pick. Unsubscribe anytime.